| ERβ | Estrogen receptor β |
| ERα | Estrogen receptor α |
| ERE | Estrogen response element |
| E2 | 17β-Estradiol |
| DC | Dendritic cell |
| Treg | Regulatory T cell |
| SERM | Selective estrogen receptor modulator |
| SERD | Selective estrogen receptor degrader |
| IHC | Immunohistochemistry |
| IF | Immunofluorescence |
| Th2 | T helper 2 |
| Th1 | T helper 1 |
| IL-4 | Interleukin-4 |
| IFNγ | Interferon Gamma |
| IL-6 | Interleukin-6 |
| TNFα | Tumor necrosis factor alpha |
| TME | Tumor microenvironment |
| EGF | Epidermal growth factor |
| IGF | Insulin growth factor |
| FGF | Fibroblast growth factor |
| OS | Overall survival |
| NSCLC | Non-small cell lung cancer |
| CAF | Cancer associated fibroblast |
| TAM | Tumor associated macrophage |
| MDSC | Myeloid derived suppressor cell |
| MPP | Methylpiperidino pyrazole |
| NK | Natural killer |
| LRH-1 | Liver receptor homolog-1 |
| PCR | Polymerase chain reaction |
| PI3K | Phosphatidylinositide 3-kinase |
| MAPK | Mitogen-activated protein kinase |
| CCL5 | C–C motif chemokine ligand 5 |
| IL-12 | Interleukin-12 |
| VEGF | Vascular endothelial growth factor |
| HGSOC | High grade serous ovarian cancer |
| IL-17A | Interleukin-17A |
| STAT3 | Signal transducer and activator of transcription 3 |
| TIL | Tumor infiltrating lymphocyte |
| AI | Aromatase inhibitor |
| CTL | Cytotoxic T lymphocyte |
| PI-9 | Proteinase inhibitor-9 |
| PD-1 | Programmed death-1 |
| PD-L1 | PD-1 ligand |
| COX-2 | Cyclooxygenase-2 |
| PGE2 | Prostaglandin E2 |
| NSAID | Nonsteroidal anti-inflammatory drug |
| AP-1 | Activator protein-1 |
| CTLA4 | Cytotoxic T-lymphocyte–associated antigen 4 |